Bortezomib in the treatment of multiple myeloma

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ghobrial, Irene M., Richardson, Paul G., Anderson, Kenneth C.
Format: Livro
Sprache:Inglês
Veröffentlicht: Springer, 2011
Ausgabe:1. ed. 2011.
Schriftenreihe:Milestones in Drug Therapy,
Schlagworte:
Oncologia.
Câncer Pesquisa.
Farmacologia.
Apoptose.
Online Zugang:https://minerva.ufrj.br/F/?func=direct&doc_number=000895347&local_base=UFR01
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge